About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Category Archives: New and Social Media
Social Media Stories in Health and Medicine – The Webicina Competition
For those not familiar with Dr. Bertalan Mesko or the tremendous resource he has created in Webicina, you are in for a treat. First a bit about Dr. Mesko – a/k/a @Berci – he is the co-founder of the site … Continue reading
Posted in New and Social Media, Social Media
Comments Off on Social Media Stories in Health and Medicine – The Webicina Competition
A Profile of Blogging by Pharma and FDA
From time to time here at Eye on FDA, the participation of Pharma and FDA on social media platforms have been examined – primarily on Twitter (see TWANK! Pharma Twitter Rankings), Facebook (see D-Day for Pharma and Facebook) and YouTube … Continue reading
Posted in New and Social Media
4 Comments
The 5th Annual Digital Pharma East Conference
This week Manhattan Research released results from a new survey that showed that 26% of U.S. adults have used their mobile telephones to access health information on the Internet in the past 12 months. The release of such a statistic … Continue reading
Posted in New and Social Media
2 Comments
Handy Twitter Lists
Twitter has emerged as one of the most active platforms for pharmaceutical companies and healthcare alike. All major government agencies working in healthcare are now on Twitter and there are at least 124 pharma and device twitter feeds (certainly more) … Continue reading
Posted in New and Social Media
3 Comments
FDA Needs Communications Expert Support
On October 3, FDA’s Center for Devices and Radiological Health (CDRH) issued a press release entitled “FDA outlines plans for an outside network of scientific experts“. The release states that the purpose of the effort is to “plan to create … Continue reading
Posted in FDA Policy, New and Social Media
1 Comment